# ClinicalTrials.gov record NCT00002779

> PeptideScanner retained ClinicalTrials.gov record NCT00002779 at 2026-07-30T21:34:56.506Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct00002779-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-12-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00002779-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00002779-octreotide-v1.json
- Content SHA-256: `0bbb88f2d5ad302d27fea0ba5461d78b99f238747881e104b40a603a41b8a80f`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00002779 ([`ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99`](#source-ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00002779 at 2026-07-30T21:34:56.506Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99`](#source-ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00002779 at 2026-07-30T21:34:56.506Z. Its registry update date was 2016-12-15, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99`](#source-ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99`](#source-ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99))

## Sources

<a id="source-ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99"></a>
- **ClinicalTrials.gov record NCT00002779 · retained source version 2016-12-15:ddf6fc5b7b99e2264de139646f8cadd166ef434779297b834466287293b46acc** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00002779) (`ctg-observation-nct00002779-2016-12-15-ddf6fc5b7b99`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00002779." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00002779-octreotide-v1.json SHA-256: 0bbb88f2d5ad302d27fea0ba5461d78b99f238747881e104b40a603a41b8a80f.